Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report)

Journal of Infection and Chemotherapy - Tập 19 - Trang 510-516 - 2013
Takeshi Tajima1, Yoshitake Sato2, Yoshikiyo Toyonaga3, Hideaki Hanaki4, Keisuke Sunakawa5
1Department of Pediatrics, Hakujikai Memorial Hospital, Tokyo, Japan
2Department of Pediatrics, Fuji Heavy Industries Health Insurance Society, Ota Memorial Hospital, Ota, Japan
3Department of Pediatrics, Sekishinkai Sayama Hospital, Sayama, Japan
4The Kitasato Institute, Kitasato University Research Center for Anti-infectious Drugs, Tokyo, Japan
5The Kitasato Institute, Kitasato University Research Organization for Infection Control Sciences, Tokyo, Japan

Tóm tắt

We previously conducted nationwide surveillance of Streptococcus pneumoniae in 2000–2001 (period 1) and 2004 (period 2) and reported the findings. Subsequent surveillance surveys conducted in 2007 (period 3) and 2010 (period 4) are now reported. Bacterial strains were clinically isolated from children with meningitis, sepsis, and respiratory tract infections at 27 hospitals participating in the Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease. Twenty-one drugs were investigated for 283 isolated strains in period 3, and 24 drugs were investigated for 459 strains in period 4. In period 3, 43.8 % of strains were penicillin-susceptible S. pneumoniae (PSSP), 52.3 % were penicillin-intermediate S. pneumoniae (PISP), and 3.9 % were penicillin-resistant S. pneumoniae (PRSP). In period 4, the percentages were PSSP 23.1 %, PISP 49.9 %, and PRSP 27.0 %. The resistance rates were 56.2 % and 76.9 %, respectively. Drug sensitivity was best with panipenem, at a minimum inhibitory concentration (MIC)90 ≤0.063 μg/ml in period 3, and with tebipenem (MIC90 ≤ 0.063 μg/ml) in period 4. Patients’ background factors related to increased bacterial resistance were investigated, and significant differences were found depending on whether a child had siblings (P = 0.0056) or was a daycare center attendee (P = 0.0195) in period 3, and age category (P = 0.0256) in period 4. No factors were common to both periods 3 and 4. Pneumococcus is a major causative organism of pediatric infectious disease, and we plan to continue conducting surveillance and providing information in the future.

Tài liệu tham khảo

Klein JO. Bacterial pneumonias. In: Feigin RD, Cherry JD, Demmler GJ, Laplan SL, editors. Textbook of pediatric infectious diseases. 5th ed. Philadelphia: Saunders; 2004. p. 299–310. Dagan R, Greenberg D, Jacobs MR. Pneumococcal infection. In: Feigin RD, Cherry JD, Demmler GJ, Laplan SL, editors. Textbook of pediatric infectious diseases, 5th ed. Philadelphia: Saunders; 2004; p. 1204–1258. Ziglam HM, Finch RG. Penicillin-resistant pneumococci: implications for management of community-acquired pneumonia and meningitis. Int J Infect Dis. 2002;6:S14–20. Sato Y, Toyonaga Y, Hanaki H, Nonoyama M, Oishi T, Sunakawa K. Nationwide survey of the development of drug-resistant pathogens in the pediatric field: drug sensitivity of Streptococcus pneumoniae in Japan. J Infect Chemother. 2009;15:396–401. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. Seventh Edition. M7-A7 26 (2). Wayne, PA: Clinical and Laboratory Standards Institute; 2006. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement. M100-S17 27(1). Wayne, PA: Clinical and Laboratory Standards Institute; 2007. Jaeklin T, Rohner P, Jacomo V, Schmidheiny K, Gervaix A. Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland. Eur J Pediatr 2006;165:3–8. Suzuki K, Kurono Y, Kobayashi T, Nishimura T, Baba S, Harabuchi Y, et al. The fourth nationwide survey of clinical isolates from patients with otolaryngological field infections (in Japanese). J Jpn Soc Infect Dis Otolaryngol 2007;26:15–26 The Committee for Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan. Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan. Tokyo: Japanese Society of Pediatric Pulmonology, Japanese Society for Pediatric Infectious Diseases; 2004, 2007 (in Japanese). The Committee for the JRS Guidelines in Management of Respiratory Infections. The JRS guidelines for the management of community-acquired pneumonia in adults. Tokyo: The Japanese Respiratory Society; 2005 (in Japanese). The Subcommittee on Clinical Practice Guidelines for the Diagnosis and Management of Acute Otitis Media in Children. Clinical practice guideline for diagnosis and management of acute otitis media (AOM) in children in Japan (in Japanese). Tokyo: Japan Otological Society, Japan Society for Pediatric Otorhinolaryngology, Japan Society for Infectious Diseases in Otolaryngology; 2006, 2009